Overexpression and Activation of the α9-Nicotinic Receptor During Tumorigenesis in Human Breast Epithelial Cells
Chia Hwa Lee,Ching Shui Huang,Ching Shyang Chen,Shih Hsin Tu,Ying Jan Wang,Yu Jia Chang,Yu Jia Chang,Ka Wai Tam,Po Li Wei,Tzu Chun Cheng,Jan Show Chu,Jan Show Chu,Li Ching Chen,Chih Hsiung Wu,Chih Hsiung Wu,Yuan Soon Ho,Yuan Soon Ho +16 more
Reads0
Chats0
TLDR
The alpha9-nAChR is important for nicotine-induced transformation of normal human breast epithelial cells and triggered precancerous transformation as defined by soft agar assay.Abstract:
BACKGROUND Large epidemiological cohort studies in the United States have indicated that active and passive smoking are associated with increased breast cancer risk. However, there was no direct evidence of an effect of tobacco carcinogens on the cellular molecules involved in breast tumorigenesis. METHODS Reverse transcription-polymerase chain reaction was used to determine the expression of all of the nicotinic acetylcholine receptor (nAChR) subunits in 50 human breast cancer samples and to determine the expression of the alpha9-nAChR subunit in 276 surgical and laser capture microdissected breast tumor vs normal tissue pairs. Stable MDA-MB-231 breast cancer cell lines were established in which expression of the alpha9-nAChR subunit was inhibited using short interfering RNA. MCF-10A normal human breast epithelial cells were established in which the alpha9-nAChR subunit could be conditionally overexpressed by removal of doxycycline from the culture fluid. Cell proliferation and soft agar assays and tumor growth in nude mice were used as measures of cell transformation. All statistical tests were two-sided. RESULTS In 186 (67.3%) of the 276 paired samples, alpha9-nAChR mRNA was expressed at (mean 7.84-fold) higher levels in breast cancers than in surrounding normal tissue. Stable expression of alpha9-nAChR short interfering RNA in MDA-MB-231 cells attenuated nicotine-stimulated proliferation and growth in soft agar and reduced tumor volume when the cells were introduced as xenografts in SCID mice (n = 5 mice per group; mean tumor volume at 6 weeks treatment in mice injected with Si alpha9 cells = 995.6 mm(3), in mice injected with parental cells = 2993.2 mm(3), difference = 1997.6 mm(3), 95% confidence interval [CI] = 1705 to 2290.2 mm(3), P = .009). Long-term treatment of MCF-10A normal breast epithelial cells with either nicotine or its active metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, triggered precancerous transformation as defined by soft agar assay. Inducible overexpression of alpha9-nAChR in MCF-10A cell xenografts in nude mice substantially increased tumor growth (n = 5 mice per group; DOX+, mean tumor volume without nicotine vs with nicotine = 266.2 vs 501.6 mm(3), difference = 235.4 mm(3), 95% CI = 112.7 to 358 mm(3), P = .009; DOX-, mean tumor volume without nicotine vs with nicotine = 621.2 vs 898.6 mm(3), difference = 277.4 mm(3), 95% CI = 98.1 to 456.7 mm(3), P = .016; mean tumor volume in the presence of nicotine, DOX+ vs DOX- = 501.6 vs 898.6 mm(3), difference = 397 mm(3), 95% CI = 241.3 to 552.6 mm(3), P = .009). CONCLUSION The alpha9-nAChR is important for nicotine-induced transformation of normal human breast epithelial cells.read more
Citations
More filters
Book ChapterDOI
Muscarinic receptor agonists and antagonists: effects on cancer.
TL;DR: The ability of muscarinic agonists to stimulate, and M3 antagonists to inhibit tumor growth has clearly been demonstrated for lung and colon cancer, and the potential role of these drugs as adjuvants to current cancer therapies is supported.
Journal ArticleDOI
Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.
TL;DR: The aim of this review is to describe the most recent findings concerning the structure and function of native nAChRs inside and outside the nervous system.
Journal ArticleDOI
1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit
Wei Zhao,Limin Wang,Haibo Han,Kemin Jin,Na Lin,Ting Guo,Yangde Chen,Heping Cheng,Fengmin Lu,Weigang Fang,Yu Wang,Baocai Xing,Zhiqian Zhang +12 more
TL;DR: A monoclonal antibody against recurrent HCC, 1B50-1, was generated that bound the isoform 5 of the α2δ1 subunit of voltage-gated calcium channels and identified a subset of tumor-initiating cells (TICs) with stem cell-like properties and had a therapeutic effect on HCC engraftments by eliminating TICs.
Journal ArticleDOI
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
TL;DR: The latest evidence concerning the role of genomic alteration in current TNBC treatment responses, current clinical trials and potential targeting sites, CSC and drug resistance, and potential strategies targeting CSCs in TNBC are surveyed.
Journal ArticleDOI
Nicotinic acetylcholine receptor signaling in tumor growth and metastasis.
TL;DR: This paper examines the historical data connecting nicotine tumor progression and the recent efforts to target the nicotinic acetylcholine receptors to combat cancer.
References
More filters
Journal ArticleDOI
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
Katjuša Brejc,W.J. van Dijk,Remco V. Klaassen,M. Schuurmans,J. van der Oost,J. van der Oost,August B. Smit,Titia K. Sixma +7 more
TL;DR: The crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homologue of the amino-terminal ligand-binding domain of an nAChR α-subunit, is presented and is relevant for the development of drugs against Alzheimer’s disease and nicotine addiction.
Journal ArticleDOI
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak,Nicholas Bertos,Francois Pepin,Francois Pepin,Svetlana Sadekova,Margarita Souleimanova,Hong Zhao,Haiying Chen,Gulbeyaz Omeroglu,Sarkis Meterissian,Atilla Omeroglu,Michael Hallett,Morag Park,Morag Park +13 more
TL;DR: Genes represented in the new stroma-derived prognostic predictor (SDPP) reveal the strong prognostic capacity of differential immune responses as well as angiogenic and hypoxic responses, highlighting the importance of stromal biology in tumor progression.
Journal ArticleDOI
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
Christopher I. Amos,Xifeng Wu,Peter Broderick,Ivan P. Gorlov,Jian Gu,Timothy Eisen,Qiong Dong,Qing Zhang,Xiangjun Gu,Jayaram Vijayakrishnan,Kate Sullivan,Athena Matakidou,Yufei Wang,Gordon B. Mills,Kimberly F. Doheny,Ya Yu Tsai,Wei Vivien Chen,Sanjay Shete,Margaret R. Spitz,Richard S. Houlston +19 more
TL;DR: Two SNPs, rs1051730 and rs8034191, mapping to a region of strong linkage disequilibrium within 15q25.1 containing PSMA4 and the nicotinic acetylcholine receptor subunit genes CHRNA3 and CHRNA5, were significantly associated with risk in both replication sets.
Journal ArticleDOI
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung,James McKay,Valerie Gaborieau,Paolo Boffetta,Mia Hashibe,David Zaridze,Anush Mukeria,Neonilia Szeszenia-Dabrowska,Jolanta Lissowska,Peter Rudnai,Eleonora Fabianova,Dana Mates,Vladimir Bencko,Lenka Foretova,Vladimir Janout,Chu Chen,Gary E. Goodman,John K. Field,Triantafillos Liloglou,George Xinarianos,Adrian Cassidy,John R. McLaughlin,Geoffrey Liu,Steven A. Narod,Hans E. Krokan,Frank Skorpen,Maiken Bratt Elvestad,Kristian Hveem,Lars J. Vatten,Jakob Linseisen,Françoise Clavel-Chapelon,Paolo Vineis,H. Bas Bueno-de-Mesquita,Eiliv Lund,Carmen Martinez,Sheila Bingham,Torgny Rasmuson,Pierre Hainaut,Elio Riboli,Wolfgang Ahrens,Simone Benhamou,Pagona Lagiou,Dimitrios Trichopoulos,Ivana Holcatova,Franco Merletti,Kristina Kjærheim,Antonio Agudo,Gary J. Macfarlane,Renato Talamini,Lorenzo Simonato,Ray Lowry,David I. Conway,Ariana Znaor,Claire M. Healy,Diana Zelenika,Anne Boland,Marc Delepine,Mario Foglio,Doris Lechner,Fumihiko Matsuda,Hélène Blanché,Ivo Gut,Simon Heath,Mark Lathrop,Paul Brennan +64 more
TL;DR: The results provide compelling evidence of a locus at 15q25 predisposing to lung cancer, and reinforce interest in nicotinic acetylcholine receptors as potential disease candidates and chemopreventative targets.
Journal ArticleDOI
α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells
TL;DR: The results suggest that the α9 receptor is involved in the cholinergic efferent innervation of cochlear hair cells and thus may modulate the encoding of auditory stimuli.